author_facet Mazzanti, Chiara
Zeiger, Martha A.
Costourous, Nick
Umbricht, Christopher
Westra, William H
Smith, Danelle
Somervell, Helina
Bevilacqua, Generoso
Alexander, H. Richard
Libutti, Steven K.
Mazzanti, Chiara
Zeiger, Martha A.
Costourous, Nick
Umbricht, Christopher
Westra, William H
Smith, Danelle
Somervell, Helina
Bevilacqua, Generoso
Alexander, H. Richard
Libutti, Steven K.
author Mazzanti, Chiara
Zeiger, Martha A.
Costourous, Nick
Umbricht, Christopher
Westra, William H
Smith, Danelle
Somervell, Helina
Bevilacqua, Generoso
Alexander, H. Richard
Libutti, Steven K.
spellingShingle Mazzanti, Chiara
Zeiger, Martha A.
Costourous, Nick
Umbricht, Christopher
Westra, William H
Smith, Danelle
Somervell, Helina
Bevilacqua, Generoso
Alexander, H. Richard
Libutti, Steven K.
Cancer Research
Using Gene Expression Profiling to Differentiate Benign versus Malignant Thyroid Tumors
Cancer Research
Oncology
author_sort mazzanti, chiara
spelling Mazzanti, Chiara Zeiger, Martha A. Costourous, Nick Umbricht, Christopher Westra, William H Smith, Danelle Somervell, Helina Bevilacqua, Generoso Alexander, H. Richard Libutti, Steven K. 0008-5472 1538-7445 American Association for Cancer Research (AACR) Cancer Research Oncology http://dx.doi.org/10.1158/0008-5472.can-03-3811 <jats:title>Abstract</jats:title> <jats:p>DNA microarrays allow quick and complete evaluation of a cell’s transcriptional activity. Expression genomics is very powerful in that it can generate expression data for a large number of genes simultaneously across multiple samples. In cancer research, an intriguing application of expression arrays includes assessing the molecular components of the neoplastic process and utilizing the data for cancer classification (Miller LD, et al. Cancer Cell 2002;2:353–61). Classification of human cancers into distinct groups based on their molecular profile rather than their histological appearance may prove to be more relevant to specific cancer diagnoses and cancer treatment regimes. Several attempts to formulate a consensus about classification and treatment of thyroid carcinoma based on standard histopathological analysis have resulted in published guidelines for diagnosis and initial disease management (Sherman SI. Lancet 2003;361:501–11). In the past few decades, no improvement has been made in the differential diagnosis of thyroid tumors by fine needle aspiration biopsy, specifically suspicious or indeterminate thyroid lesions, suggesting that a new approach to this should be explored. Therefore, in this study, we developed a gene expression approach to diagnose benign versus malignant thyroid lesions in 73 patients with thyroid tumors. We successfully built a 10 and 6 gene model able to differentiate benign versus malignant thyroid tumors. Our results support the premise that a molecular classification system for thyroid tumors is possible, and this in turn may provide a more accurate diagnostic tool for the clinician managing patients with suspicious thyroid lesions.</jats:p> Using Gene Expression Profiling to Differentiate Benign <b> <i>versus</i> </b> Malignant Thyroid Tumors Cancer Research
doi_str_mv 10.1158/0008-5472.can-03-3811
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8wMDA4LTU0NzIuY2FuLTAzLTM4MTE
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8wMDA4LTU0NzIuY2FuLTAzLTM4MTE
institution DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
imprint American Association for Cancer Research (AACR), 2004
imprint_str_mv American Association for Cancer Research (AACR), 2004
issn 1538-7445
0008-5472
issn_str_mv 1538-7445
0008-5472
language English
mega_collection American Association for Cancer Research (AACR) (CrossRef)
match_str mazzanti2004usinggeneexpressionprofilingtodifferentiatebenignversusmalignantthyroidtumors
publishDateSort 2004
publisher American Association for Cancer Research (AACR)
recordtype ai
record_format ai
series Cancer Research
source_id 49
title Using Gene Expression Profiling to Differentiate Benign versus Malignant Thyroid Tumors
title_unstemmed Using Gene Expression Profiling to Differentiate Benign versus Malignant Thyroid Tumors
title_full Using Gene Expression Profiling to Differentiate Benign versus Malignant Thyroid Tumors
title_fullStr Using Gene Expression Profiling to Differentiate Benign versus Malignant Thyroid Tumors
title_full_unstemmed Using Gene Expression Profiling to Differentiate Benign versus Malignant Thyroid Tumors
title_short Using Gene Expression Profiling to Differentiate Benign versus Malignant Thyroid Tumors
title_sort using gene expression profiling to differentiate benign <b> <i>versus</i> </b> malignant thyroid tumors
topic Cancer Research
Oncology
url http://dx.doi.org/10.1158/0008-5472.can-03-3811
publishDate 2004
physical 2898-2903
description <jats:title>Abstract</jats:title> <jats:p>DNA microarrays allow quick and complete evaluation of a cell’s transcriptional activity. Expression genomics is very powerful in that it can generate expression data for a large number of genes simultaneously across multiple samples. In cancer research, an intriguing application of expression arrays includes assessing the molecular components of the neoplastic process and utilizing the data for cancer classification (Miller LD, et al. Cancer Cell 2002;2:353–61). Classification of human cancers into distinct groups based on their molecular profile rather than their histological appearance may prove to be more relevant to specific cancer diagnoses and cancer treatment regimes. Several attempts to formulate a consensus about classification and treatment of thyroid carcinoma based on standard histopathological analysis have resulted in published guidelines for diagnosis and initial disease management (Sherman SI. Lancet 2003;361:501–11). In the past few decades, no improvement has been made in the differential diagnosis of thyroid tumors by fine needle aspiration biopsy, specifically suspicious or indeterminate thyroid lesions, suggesting that a new approach to this should be explored. Therefore, in this study, we developed a gene expression approach to diagnose benign versus malignant thyroid lesions in 73 patients with thyroid tumors. We successfully built a 10 and 6 gene model able to differentiate benign versus malignant thyroid tumors. Our results support the premise that a molecular classification system for thyroid tumors is possible, and this in turn may provide a more accurate diagnostic tool for the clinician managing patients with suspicious thyroid lesions.</jats:p>
container_issue 8
container_start_page 2898
container_title Cancer Research
container_volume 64
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792341167795339266
geogr_code not assigned
last_indexed 2024-03-01T16:15:37.449Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Using+Gene+Expression+Profiling+to+Differentiate+Benign++++++++++++++++++++++versus+++++++++++++++++++Malignant+Thyroid+Tumors&rft.date=2004-04-15&genre=article&issn=1538-7445&volume=64&issue=8&spage=2898&epage=2903&pages=2898-2903&jtitle=Cancer+Research&atitle=Using+Gene+Expression+Profiling+to+Differentiate+Benign+%3Cb%3E%0A+++++++++++++++++++++%3Ci%3Eversus%3C%2Fi%3E%0A++++++++++++++++++%3C%2Fb%3E+Malignant+Thyroid+Tumors&aulast=Libutti&aufirst=Steven+K.&rft_id=info%3Adoi%2F10.1158%2F0008-5472.can-03-3811&rft.language%5B0%5D=eng
SOLR
_version_ 1792341167795339266
author Mazzanti, Chiara, Zeiger, Martha A., Costourous, Nick, Umbricht, Christopher, Westra, William H, Smith, Danelle, Somervell, Helina, Bevilacqua, Generoso, Alexander, H. Richard, Libutti, Steven K.
author_facet Mazzanti, Chiara, Zeiger, Martha A., Costourous, Nick, Umbricht, Christopher, Westra, William H, Smith, Danelle, Somervell, Helina, Bevilacqua, Generoso, Alexander, H. Richard, Libutti, Steven K., Mazzanti, Chiara, Zeiger, Martha A., Costourous, Nick, Umbricht, Christopher, Westra, William H, Smith, Danelle, Somervell, Helina, Bevilacqua, Generoso, Alexander, H. Richard, Libutti, Steven K.
author_sort mazzanti, chiara
container_issue 8
container_start_page 2898
container_title Cancer Research
container_volume 64
description <jats:title>Abstract</jats:title> <jats:p>DNA microarrays allow quick and complete evaluation of a cell’s transcriptional activity. Expression genomics is very powerful in that it can generate expression data for a large number of genes simultaneously across multiple samples. In cancer research, an intriguing application of expression arrays includes assessing the molecular components of the neoplastic process and utilizing the data for cancer classification (Miller LD, et al. Cancer Cell 2002;2:353–61). Classification of human cancers into distinct groups based on their molecular profile rather than their histological appearance may prove to be more relevant to specific cancer diagnoses and cancer treatment regimes. Several attempts to formulate a consensus about classification and treatment of thyroid carcinoma based on standard histopathological analysis have resulted in published guidelines for diagnosis and initial disease management (Sherman SI. Lancet 2003;361:501–11). In the past few decades, no improvement has been made in the differential diagnosis of thyroid tumors by fine needle aspiration biopsy, specifically suspicious or indeterminate thyroid lesions, suggesting that a new approach to this should be explored. Therefore, in this study, we developed a gene expression approach to diagnose benign versus malignant thyroid lesions in 73 patients with thyroid tumors. We successfully built a 10 and 6 gene model able to differentiate benign versus malignant thyroid tumors. Our results support the premise that a molecular classification system for thyroid tumors is possible, and this in turn may provide a more accurate diagnostic tool for the clinician managing patients with suspicious thyroid lesions.</jats:p>
doi_str_mv 10.1158/0008-5472.can-03-3811
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8wMDA4LTU0NzIuY2FuLTAzLTM4MTE
imprint American Association for Cancer Research (AACR), 2004
imprint_str_mv American Association for Cancer Research (AACR), 2004
institution DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229
issn 1538-7445, 0008-5472
issn_str_mv 1538-7445, 0008-5472
language English
last_indexed 2024-03-01T16:15:37.449Z
match_str mazzanti2004usinggeneexpressionprofilingtodifferentiatebenignversusmalignantthyroidtumors
mega_collection American Association for Cancer Research (AACR) (CrossRef)
physical 2898-2903
publishDate 2004
publishDateSort 2004
publisher American Association for Cancer Research (AACR)
record_format ai
recordtype ai
series Cancer Research
source_id 49
spelling Mazzanti, Chiara Zeiger, Martha A. Costourous, Nick Umbricht, Christopher Westra, William H Smith, Danelle Somervell, Helina Bevilacqua, Generoso Alexander, H. Richard Libutti, Steven K. 0008-5472 1538-7445 American Association for Cancer Research (AACR) Cancer Research Oncology http://dx.doi.org/10.1158/0008-5472.can-03-3811 <jats:title>Abstract</jats:title> <jats:p>DNA microarrays allow quick and complete evaluation of a cell’s transcriptional activity. Expression genomics is very powerful in that it can generate expression data for a large number of genes simultaneously across multiple samples. In cancer research, an intriguing application of expression arrays includes assessing the molecular components of the neoplastic process and utilizing the data for cancer classification (Miller LD, et al. Cancer Cell 2002;2:353–61). Classification of human cancers into distinct groups based on their molecular profile rather than their histological appearance may prove to be more relevant to specific cancer diagnoses and cancer treatment regimes. Several attempts to formulate a consensus about classification and treatment of thyroid carcinoma based on standard histopathological analysis have resulted in published guidelines for diagnosis and initial disease management (Sherman SI. Lancet 2003;361:501–11). In the past few decades, no improvement has been made in the differential diagnosis of thyroid tumors by fine needle aspiration biopsy, specifically suspicious or indeterminate thyroid lesions, suggesting that a new approach to this should be explored. Therefore, in this study, we developed a gene expression approach to diagnose benign versus malignant thyroid lesions in 73 patients with thyroid tumors. We successfully built a 10 and 6 gene model able to differentiate benign versus malignant thyroid tumors. Our results support the premise that a molecular classification system for thyroid tumors is possible, and this in turn may provide a more accurate diagnostic tool for the clinician managing patients with suspicious thyroid lesions.</jats:p> Using Gene Expression Profiling to Differentiate Benign <b> <i>versus</i> </b> Malignant Thyroid Tumors Cancer Research
spellingShingle Mazzanti, Chiara, Zeiger, Martha A., Costourous, Nick, Umbricht, Christopher, Westra, William H, Smith, Danelle, Somervell, Helina, Bevilacqua, Generoso, Alexander, H. Richard, Libutti, Steven K., Cancer Research, Using Gene Expression Profiling to Differentiate Benign versus Malignant Thyroid Tumors, Cancer Research, Oncology
title Using Gene Expression Profiling to Differentiate Benign versus Malignant Thyroid Tumors
title_full Using Gene Expression Profiling to Differentiate Benign versus Malignant Thyroid Tumors
title_fullStr Using Gene Expression Profiling to Differentiate Benign versus Malignant Thyroid Tumors
title_full_unstemmed Using Gene Expression Profiling to Differentiate Benign versus Malignant Thyroid Tumors
title_short Using Gene Expression Profiling to Differentiate Benign versus Malignant Thyroid Tumors
title_sort using gene expression profiling to differentiate benign <b> <i>versus</i> </b> malignant thyroid tumors
title_unstemmed Using Gene Expression Profiling to Differentiate Benign versus Malignant Thyroid Tumors
topic Cancer Research, Oncology
url http://dx.doi.org/10.1158/0008-5472.can-03-3811